• Podcast
  • 31/03/2019
  • UK

Cell Therapy in Orthopaedics: Where Are We in 2019?

Description

The fifth podcast from The Bone & Joint Journal features Andrew Duckworth as the host, who expresses gratitude towards listeners and contributors for their support. The episode covers a variety of past topics, such as the management of open fractures and robotic knee replacements, and aims to enhance the accessibility of the journal's published work.



In this episode, Andrew introduces guest interviewer Ian Murray, alongside Dr. Scott Rodeo, who specializes in cell therapy in orthopaedics. They discuss the terminology and relevance of 'orthobiologics', a term encompassing blood-based therapies designed to improve tissue healing in areas usually characterized by poor regeneration capacity. Dr. Rodeo emphasizes the promise of biologics, particularly for treating arthritis and facilitating recovery from rotator cuff injuries, albeit noting the need for solid research to ascertain their efficacy.



The conversation highlights a pressing need for standardized protocols in biologics, leaving practitioners to handle varying formulations and applications. Dr. Rodeo advocates for rigorous patient education on the current state of evidence surrounding these therapies. The podcast wraps up with a call for collective efforts in research, regulation, and clinical practice to responsibly advance the use of biologics in orthopaedic treatments.

DOI: 10.1302/3114-210469

Specialties